CComputing Read More Can Quantum Computing’s Government Contracts Boost Future Growth?September 19, 2025 Quantum Computing Inc. or “QCi” QUBT is continuously focused on strengthening its engagement with strategic government partners. During…
CComputing Read More QUBT Gains Commercial Traction With Quantum AI and Cybersecurity Deals (Revised)September 17, 2025 During the second quarter of 2025, Quantum Computing Inc. QUBT, or QCi, sold its EmuCore reservoir computing device…
HHealthcare Read More NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to BuySeptember 13, 2025 The global AI in healthcare market is experiencing explosive growth. According to a Fortune Business Insights report, the…
CComputing Read More QUBT Gains Commercial Traction With Quantum AI and Cybersecurity DealsSeptember 10, 2025 During the second quarter of 2025, Quantum Computing Inc. (QUBT), or QCi, sold its EmuCore reservoir computing device…
HHealthcare Read More Can Technology Redefine Healthcare Efficiency?September 9, 2025 The largest health insurer in the United States, UnitedHealth Group Incorporated UNH, is increasingly incorporating artificial intelligence (AI)…
PPersonal finance Read More Can FUTU’s Wealth Management Take Off?September 6, 2025 Futu Holdings Limited FUTU reported a record year-over-year client asset surge of 68.1% and a sequential 17.4% rise…
PPhysics Read More Quantum Computing Expands Global Reach With New Research CollabsSeptember 3, 2025 Quantum Computing Inc. QUBT or QCi continues to gain traction among key academic and research partners worldwide. Recently,…
CComputing Read More Which Quantum Computing Stock Is the Smarter Buy?August 30, 2025 Quantum computing is moving from lab prototypes to commercial pathways, and for investors, two pure-play names, Rigetti Computing…
CComputing Read More Can Rigetti Computing’s Margin Recover After Second-Quarter Pressure?August 29, 2025 Rigetti Computing’s RGTI second-quarter 2025 results gave investors a closer look at the pressures weighing on margins as…
HHealthcare Read More GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EUAugust 28, 2025 Gilead Sciences, Inc. (GILD) announced that the European Commission (“EC”) has granted marketing authorization to HIV prevention drug…
MMental health Read More ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for DepressionAugust 27, 2025 AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…
HHealthcare Read More 4 Medical Devices Behemoths to Buy Amid Extensive AI ApplicationsAugust 27, 2025 Rising demand for precision and personalized medicine has significantly augmented the need for artificial intelligence (AI)-enabled medical devices…